Why the study?
Few studies have reported the prognostic effects of the Kansas City Cardiomyopathy Questionnaire (KCCQ) in patients with acute HF.
Cohort (n=4,898)
Yes
Effect estimate: 13% increase in 30-day risk and 7% increase in 1-year risk per 10-point decrease
The KCCQ-12 score assessed within 48 hours of admission for acute heart failure provides significant prognostic value for short- and long-term cardiovascular death and HF rehospitalization, incremental to NT-proBNP and established risk scores.
Supports KCCQ-12 for acute HF prognostication; extends prior data but leaves open prospective validation.
OBJECTIVES: This study aims to examine the association between the Kansas City Cardiomyopathy Questionnaire (KCCQ)-12 score and the 30-day and 1-year rates of composite events of cardiovascular death and heart failure (HF) rehospitalization in patients with acute HF. BACKGROUND: Few studies reported the prognostic effects of KCCQ in acute HF. METHODS: This study prospectively enrolled adult patients hospitalized for HF from 52 hospitals in China and collected the KCCQ-12 score within 48 hour of index admission. The study used multivariable Cox regression to examine the association between KCCQ-12 score and 30-day and 1-year composite events and was further stratified by new-onset HF and acutely decompensated chronic heart failure (ADCHF). Subgroup analyses were performed to explore the potential heterogeneity. The study evaluated the incremental prognostic value of KCCQ-12 score over N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels and established risk scores by C-statistics, net reclassification improvement, and integrated discrimination improvement. RESULTS: Among 4,898 patients, 29.4% had new-onset HF. After adjustment, each 10-point decrease in the KCCQ-12 score was associated with a 13% increase in 30-day risk and a 7% increase in 1-year risk. The associations were consistent regardless of new-onset HF or ADCHF, age, sex, left ventricular ejection fraction, New York Heart Association functional class, NT-proBNP level, comorbidities, and renal function. Adding KCCQ-12 score to NT-proBNP and established risk scores significantly improved prognostic capabilities measured by C-statistics, net reclassification improvement, and integrated discrimination improvement. CONCLUSIONS: In acute HF, a poor KCCQ-12 score predicted short- and long-term risks of cardiovascular death and HF rehospitalization. KCCQ-12 could serve as a convenient tool for rapid initial risk stratification and provide additional prognostic value over NT-proBNP and established risk scores.
No takes yet. Share an insight, caveat, or question.
Hu et al. (2021) conducted a cohort in Acute heart failure (n=4,898). Kansas City Cardiomyopathy Questionnaire (KCCQ)-12 score was evaluated on Composite events of cardiovascular death and heart failure (HF) rehospitalization (13% increase in 30-day risk and 7% increase in 1-year risk per 10-point decrease).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: